{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:23:53Z","timestamp":1707524633140},"reference-count":44,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,22]]},"DOI":"10.7759\/cureus.28265","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T16:34:56Z","timestamp":1661186096000},"source":"Crossref","is-referenced-by-count":0,"title":["The Actions of Lithium on Glaucoma and Other Senile Neurodegenerative Diseases Through GSK-3 Inhibition: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Arihant","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanishq","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek R","family":"Velagala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swedaj","family":"Thakre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61423-7","article-title":"Glaucoma","volume":"377","author":"Quigley HA","year":"2011","unstructured":"Quigley HA. Glaucoma. Lancet. 2011, 377:1367-77. 10.1016\/S0140-6736(10)61423-7","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2005.083733","article-title":"The epidemiology of age related eye diseases in Asia","volume":"90","author":"Wong TY","year":"2006","unstructured":"Wong TY, Loon SC, Saw SM. The epidemiology of age related eye diseases in Asia. Br J Ophthalmol. 2006, 90:506-11. 10.1136\/bjo.2005.083733","journal-title":"Br J Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham YC","year":"2014","unstructured":"Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014, 121:2081-90. 10.1016\/j.ophtha.2014.05.013","journal-title":"Ophthalmology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.21899","article-title":"Glaucoma in adults-screening, diagnosis, and management: A review","volume":"325","author":"Stein JD","year":"2021","unstructured":"Stein JD, Khawaja AP, Weizer JS. Glaucoma in adults-screening, diagnosis, and management: A review. JAMA. 2021, 325:164-74. 10.1001\/jama.2020.21899","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2015.120","article-title":"Dementia is associated with open-angle glaucoma: a population-based study","volume":"29","author":"Chung SD","year":"2015","unstructured":"Chung SD, Ho JD, Chen CH, Lin HC, Tsai MC, Sheu JJ. Dementia is associated with open-angle glaucoma: a population-based study. Eye (Lond). 2015, 29:1340-6. 10.1038\/eye.2015.120","journal-title":"Eye (Lond)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002833","article-title":"Association between glaucoma and the risk of dementia","volume":"95","author":"Su CW","year":"2016","unstructured":"Su CW, Lin CC, Kao CH, Chen HY. Association between glaucoma and the risk of dementia. Medicine (Baltimore). 2016, 95:e2833. 10.1097\/MD.0000000000002833","journal-title":"Medicine (Baltimore)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2017.00214","article-title":"The role of microglia in retinal neurodegeneration: Alzheimer's disease, Parkinson, and glaucoma","volume":"9","author":"Ramirez AI","year":"2017","unstructured":"Ramirez AI, de Hoz R, Salobrar-Garcia E, et al.. The role of microglia in retinal neurodegeneration: Alzheimer's disease, Parkinson, and glaucoma. Front Aging Neurosci. 2017, 9:214. 10.3389\/fnagi.2017.00214","journal-title":"Front Aging Neurosci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1021\/cn500040g","article-title":"A new avenue for lithium: intervention in traumatic brain injury","volume":"5","author":"Leeds PR","year":"2014","unstructured":"Leeds PR, Yu F, Wang Z, et al.. A new avenue for lithium: intervention in traumatic brain injury. ACS Chem Neurosci. 2014, 5:422-33. 10.1021\/cn500040g","journal-title":"ACS Chem Neurosci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073798","article-title":"Cannabidiol and the canonical WNT\/\u03b2-catenin pathway in glaucoma","volume":"22","author":"Vall\u00e9e A","year":"2021","unstructured":"Vall\u00e9e A, Lecarpentier Y, Vall\u00e9e JN. Cannabidiol and the canonical WNT\/\u03b2-catenin pathway in glaucoma. Int J Mol Sci. 2021, 22:10.3390\/ijms22073798","journal-title":"Int J Mol Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18122679","article-title":"An oldie but goodie: Lithium in the treatment of bipolar disorder through neuroprotective and neurotrophic mechanisms","volume":"18","author":"Won E","year":"2017","unstructured":"Won E, Kim YK. An oldie but goodie: Lithium in the treatment of bipolar disorder through neuroprotective and neurotrophic mechanisms. Int J Mol Sci. 2017, 18:10.3390\/ijms18122679","journal-title":"Int J Mol Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2017.0204","article-title":"The prevalence of glaucoma in young people","volume":"114","author":"Marx-Gross S","year":"2017","unstructured":"Marx-Gross S, Laubert-Reh D, Schneider A, et al.. The prevalence of glaucoma in young people. Dtsch Arztebl Int. 2017, 114:204-10. 10.3238\/arztebl.2017.0204","journal-title":"Dtsch Arztebl Int"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2021.01.004","article-title":"Glaucoma","volume":"105","author":"Kang JM","year":"2021","unstructured":"Kang JM, Tanna AP. Glaucoma. Med Clin North Am. 2021, 105:493-510. 10.1016\/j.mcna.2021.01.004","journal-title":"Med Clin North Am"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11686","article-title":"Epidemiology of glaucoma: The past, present, and predictions for the future","volume":"12","author":"Allison K","year":"2020","unstructured":"Allison K, Patel D, Alabi O. Epidemiology of glaucoma: The past, present, and predictions for the future. Cureus. 2020, 12:e11686. 10.7759\/cureus.11686","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0b013e3181c4ac5b","article-title":"Glaucoma in India: estimated burden of disease","volume":"19","author":"George R","year":"2010","unstructured":"George R, Ve RS, Vijaya L. Glaucoma in India: estimated burden of disease. J Glaucoma. 2010, 19:391-7. 10.1097\/IJG.0b013e3181c4ac5b","journal-title":"J Glaucoma"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-307223","article-title":"Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): a systematic review and meta-analysis","volume":"100","author":"Kapetanakis VV","year":"2016","unstructured":"Kapetanakis VV, Chan MP, Foster PJ, Cook DG, Owen CG, Rudnicka AR. Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): a systematic review and meta-analysis. Br J Ophthalmol. 2016, 100:86-93. 10.1136\/bjophthalmol-2015-307223","journal-title":"Br J Ophthalmol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-019-0671-0","article-title":"New glaucoma medications: latanoprostene bunod, netarsudil, and fixed combination netarsudil-latanoprost","volume":"34","author":"Mehran NA","year":"2020","unstructured":"Mehran NA, Sinha S, Razeghinejad R. New glaucoma medications: latanoprostene bunod, netarsudil, and fixed combination netarsudil-latanoprost. Eye (Lond). 2020, 34:72-88. 10.1038\/s41433-019-0671-0","journal-title":"Eye (Lond)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1981.03930010635009","article-title":"Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage","volume":"99","author":"Quigley HA","year":"1981","unstructured":"Quigley HA, Addicks EM, Green WR, Maumenee AE. Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage. Arch Ophthalmol. 1981, 99:635-49. 10.1001\/archopht.1981.03930010635009","journal-title":"Arch Ophthalmol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2004.06.001","article-title":"The optic nerve head as a biomechanical structure: a new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage","volume":"24","author":"Burgoyne CF","year":"2005","unstructured":"Burgoyne CF, Downs JC, Bellezza AJ, Suh JK, Hart RT. The optic nerve head as a biomechanical structure: a new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage. Prog Retin Eye Res. 2005, 24:39-73. 10.1016\/j.preteyeres.2004.06.001","journal-title":"Prog Retin Eye Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/s0039-6257(05)80042-6","article-title":"Mechanisms of optic nerve damage in primary open angle glaucoma","volume":"39","author":"Fechtner RD","year":"1994","unstructured":"Fechtner RD, Weinreb RN. Mechanisms of optic nerve damage in primary open angle glaucoma. Surv Ophthalmol. 1994, 39:23-42. 10.1016\/s0039-6257(05)80042-6","journal-title":"Surv Ophthalmol"},{"key":"ref20","article-title":"Eye conditions in older adults: Open-angle glaucoma","volume":"445","author":"Iroku-Malize T","year":"2016","unstructured":"Iroku-Malize T, Kirsch S. Eye conditions in older adults: Open-angle glaucoma. FP Essent. 2016, 445:11-6.","journal-title":"FP Essent"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.18632\/aging.100853","article-title":"Age-related neuroinflammation and changes in AKT-GSK-3\u03b2 and WNT\/ \u03b2-CATENIN signaling in rat hippocampus","volume":"7","author":"Orellana AM","year":"2015","unstructured":"Orellana AM, Vasconcelos AR, Leite JA, et al.. Age-related neuroinflammation and changes in AKT-GSK-3\u03b2 and WNT\/ \u03b2-CATENIN signaling in rat hippocampus. Aging (Albany NY). 2015, 7:1094-111. 10.18632\/aging.100853","journal-title":"Aging (Albany NY)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-9664","article-title":"Existence of the canonical Wnt signaling pathway in the human trabecular meshwork","volume":"53","author":"Mao W","year":"2012","unstructured":"Mao W, Millar JC, Wang WH, et al.. Existence of the canonical Wnt signaling pathway in the human trabecular meshwork. Invest Ophthalmol Vis Sci. 2012, 53:7043-51. 10.1167\/iovs.12-9664","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9050473","article-title":"Lithium and atypical antipsychotics: The possible WNT\/\u03b2 pathway target in glaucoma","volume":"9","author":"Vall\u00e9e A","year":"2021","unstructured":"Vall\u00e9e A, Vall\u00e9e JN, Lecarpentier Y. Lithium and atypical antipsychotics: The possible WNT\/\u03b2 pathway target in glaucoma. Biomedicines. 2021, 9:10.3390\/biomedicines9050473","journal-title":"Biomedicines"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.17-21964","article-title":"The role of Wnt\/\u03b2-catenin signaling and K-cadherin in the regulation of intraocular pressure","volume":"59","author":"Webber HC","year":"2018","unstructured":"Webber HC, Bermudez JY, Millar JC, Mao W, Clark AF. The role of Wnt\/\u03b2-catenin signaling and K-cadherin in the regulation of intraocular pressure. Invest Ophthalmol Vis Sci. 2018, 59:1454-66. 10.1167\/iovs.17-21964","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2004.02422.x","article-title":"Glycogen synthase kinase 3: a drug target for CNS therapies","volume":"89","author":"Bhat RV","year":"2004","unstructured":"Bhat RV, Budd Haeberlein SL, Avila J. Glycogen synthase kinase 3: a drug target for CNS therapies. J Neurochem. 2004, 89:1313-7. 10.1111\/j.1471-4159.2004.02422.x","journal-title":"J Neurochem"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.40.25326","article-title":"Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3","volume":"272","author":"Hong M","year":"1997","unstructured":"Hong M, Chen DC, Klein PS, Lee VM. Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3. J Biol Chem. 1997, 272:25326-32. 10.1074\/jbc.272.40.25326","journal-title":"J Biol Chem"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-5793(99)00685-7","article-title":"Lithium protects cultured neurons against beta-amyloid-induced neurodegeneration","volume":"453","author":"Alvarez G","year":"1999","unstructured":"Alvarez G, Mu\u00f1oz-Monta\u00f1o JR, Satr\u00fastegui J, Avila J, Bog\u00f3nez E, D\u00edaz-Nido J. Lithium protects cultured neurons against beta-amyloid-induced neurodegeneration. FEBS Lett. 1999, 453:260-4. 10.1016\/s0014-5793(99)00685-7","journal-title":"FEBS Lett"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.01562","article-title":"Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3","volume":"118","author":"Kim AJ","year":"2005","unstructured":"Kim AJ, Shi Y, Austin RC, Werstuck GH. Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3. J Cell Sci. 2005, 118:89-99. 10.1242\/jcs.01562","journal-title":"J Cell Sci"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145712000132","article-title":"Neuroprotective effects of chronic exposure of SH-SY5Y to low lithium concentration involve glycolysis stimulation, extracellular pyruvate accumulation and resistance to oxidative stress","volume":"16","author":"Nciri R","year":"2013","unstructured":"Nciri R, Desmoulin F, Allagui MS, Murat JC, Feki AE, Vincent C, Croute F. Neuroprotective effects of chronic exposure of SH-SY5Y to low lithium concentration involve glycolysis stimulation, extracellular pyruvate accumulation and resistance to oxidative stress. Int J Neuropsychopharmacol. 2013, 16:365-76. 10.1017\/S1461145712000132","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2015.06.018","article-title":"The combination of lithium and l-Dopa\/Carbidopa reduces MPTP-induced abnormal involuntary movements (AIMs) via calpain-1 inhibition in a mouse model: Relevance for Parkinson\u05f3s disease therapy","volume":"1622","author":"Lazzara CA","year":"2015","unstructured":"Lazzara CA, Riley RR, Rane A, Andersen JK, Kim YH. The combination of lithium and l-Dopa\/Carbidopa reduces MPTP-induced abnormal involuntary movements (AIMs) via calpain-1 inhibition in a mouse model: Relevance for Parkinson\u05f3s disease therapy. Brain Res. 2015, 1622:127-36. 10.1016\/j.brainres.2015.06.018","journal-title":"Brain Res"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2004.02.005","article-title":"Prevention of MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) dopaminergic neurotoxicity in mice by chronic lithium: involvements of Bcl-2 and Bax","volume":"46","author":"Youdim MB","year":"2004","unstructured":"Youdim MB, Arraf Z. Prevention of MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) dopaminergic neurotoxicity in mice by chronic lithium: involvements of Bcl-2 and Bax. Neuropharmacology. 2004, 46:1130-40. 10.1016\/j.neuropharm.2004.02.005","journal-title":"Neuropharmacology"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1055\/s-2003-45138","article-title":"Implications of the neuroprotective effects of lithium for the treatment of bipolar and neurodegenerative disorders","volume":"36 Suppl 3","author":"Bauer M","year":"2003","unstructured":"Bauer M, Alda M, Priller J, Young LT. Implications of the neuroprotective effects of lithium for the treatment of bipolar and neurodegenerative disorders. Pharmacopsychiatry. 2003, 36 Suppl 3:S250-4. 10.1055\/s-2003-45138","journal-title":"Pharmacopsychiatry"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.107.043133","article-title":"Lithium in mood disorders: increasing evidence base, declining use?","volume":"191","author":"Young AH","year":"2007","unstructured":"Young AH, Hammond JM. Lithium in mood disorders: increasing evidence base, declining use?. Br J Psychiatry. 2007, 191:474-6. 10.1192\/bjp.bp.107.043133","journal-title":"Br J Psychiatry"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1186\/s40345-016-0068-y","article-title":"Lithium side effects and toxicity: prevalence and management strategies","volume":"4","author":"Gitlin M","year":"2016","unstructured":"Gitlin M. Lithium side effects and toxicity: prevalence and management strategies. Int J Bipolar Disord. 2016, 4:27. 10.1186\/s40345-016-0068-y","journal-title":"Int J Bipolar Disord"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.1999.010201.x","article-title":"Lithium therapy at the millennium: a revolutionary drug used for 50 years faces competing options and possible demise","volume":"1","author":"Fieve RR","year":"1999","unstructured":"Fieve RR. Lithium therapy at the millennium: a revolutionary drug used for 50 years faces competing options and possible demise. Bipolar Disord. 1999, 1:67-70. 10.1034\/j.1399-5618.1999.010201.x","journal-title":"Bipolar Disord"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1586\/14737175.2014.947965","article-title":"Lithium for bipolar disorder: a review of the recent literature","volume":"14","author":"Curran G","year":"2014","unstructured":"Curran G, Ravindran A. Lithium for bipolar disorder: a review of the recent literature. Expert Rev Neurother. 2014, 14:1079-98. 10.1586\/14737175.2014.947965","journal-title":"Expert Rev Neurother"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.2174\/1381612043383872","article-title":"Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?","volume":"10","author":"Pacher P","year":"2004","unstructured":"Pacher P, Kecskemeti V. Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?. Curr Pharm Des. 2004, 10:2463-75. 10.2174\/1381612043383872","journal-title":"Curr Pharm Des"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2010.07.008","article-title":"Neuroprotective effect and cognitive outcome of chronic lithium on traumatic brain injury in mice","volume":"83","author":"Zhu ZF","year":"2010","unstructured":"Zhu ZF, Wang QG, Han BJ, William CP. Neuroprotective effect and cognitive outcome of chronic lithium on traumatic brain injury in mice. Brain Res Bull. 2010, 83:272-7. 10.1016\/j.brainresbull.2010.07.008","journal-title":"Brain Res Bull"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4000811","article-title":"Neuroplasticity and cellular resilience in mood disorders","volume":"5","author":"Manji HK","year":"2000","unstructured":"Manji HK, Moore GJ, Rajkowska G, Chen G. Neuroplasticity and cellular resilience in mood disorders. Mol Psychiatry. 2000, 5:578-93. 10.1038\/sj.mp.4000811","journal-title":"Mol Psychiatry"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.02-0198","article-title":"Support of retinal ganglion cell survival and axon regeneration by lithium through a Bcl-2-dependent mechanism","volume":"44","author":"Huang X","year":"2003","unstructured":"Huang X, Wu DY, Chen G, Manji H, Chen DF. Support of retinal ganglion cell survival and axon regeneration by lithium through a Bcl-2-dependent mechanism. Invest Ophthalmol Vis Sci. 2003, 44:347-54. 10.1167\/iovs.02-0198","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1038\/385434a0","article-title":"Bcl-2 promotes regeneration of severed axons in mammalian CNS","volume":"385","author":"Chen DF","year":"1997","unstructured":"Chen DF, Schneider GE, Martinou JC, Tonegawa S. Bcl-2 promotes regeneration of severed axons in mammalian CNS. Nature. 1997, 385:434-9. 10.1038\/385434a0","journal-title":"Nature"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.10.040192.004033","article-title":"Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes","volume":"10","author":"Korsmeyer SJ","year":"1992","unstructured":"Korsmeyer SJ. Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes. Annu Rev Immunol. 1992, 10:785-807. 10.1146\/annurev.iy.10.040192.004033","journal-title":"Annu Rev Immunol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3390\/cells10020230","article-title":"Parkinson's disease: Potential actions of lithium by targeting the WNT\/\u03b2-catenin pathway, oxidative stress, inflammation and glutamatergic pathway","volume":"10","author":"Vall\u00e9e A","year":"2021","unstructured":"Vall\u00e9e A, Vall\u00e9e JN, Lecarpentier Y. Parkinson's disease: Potential actions of lithium by targeting the WNT\/\u03b2-catenin pathway, oxidative stress, inflammation and glutamatergic pathway. Cells. 2021, 10:10.3390\/cells10020230","journal-title":"Cells"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1124\/pr.111.005512","article-title":"Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder","volume":"65","author":"Chiu CT","year":"2013","unstructured":"Chiu CT, Wang Z, Hunsberger JG, Chuang DM. Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder. Pharmacol Rev. 2013, 65:105-42. 10.1124\/pr.111.005512","journal-title":"Pharmacol Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/107730-the-actions-of-lithium-on-glaucoma-and-other-senile-neurodegenerative-diseases-through-gsk-3-inhibition-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:38:23Z","timestamp":1707507503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/107730-the-actions-of-lithium-on-glaucoma-and-other-senile-neurodegenerative-diseases-through-gsk-3-inhibition-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,22]]},"references-count":44,"URL":"https:\/\/doi.org\/10.7759\/cureus.28265","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,22]]}}}